Johnson & Johnson (UKEX:JNJ) Change In Other Working Capital : ₴83,604 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Change In Other Working Capital?

Johnson & Johnson's Change In Other Working Capital for the quarter that ended in Dec. 2023 was ₴48,148 Mil. It means Johnson & Johnson's Other Working Capital increased by ₴48,148 Mil from Sep. 2023 to Dec. 2023 .

Johnson & Johnson's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was ₴83,604 Mil. It means Johnson & Johnson's Other Working Capital increased by ₴83,604 Mil from Dec. 2022 to Dec. 2023 .

Johnson & Johnson Change In Other Working Capital Historical Data

The historical data trend for Johnson & Johnson's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Change In Other Working Capital Chart

Johnson & Johnson Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

14,714.03

-117,394.92

-119,972.85

-51,241.30

83,604.22

Johnson & Johnson Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															214,681.99	-124,930.40	-54,295.15	48,147.78	-

Johnson & Johnson Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₴83,604 Mil.

Johnson & Johnson Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson (UKEX:JNJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Austria JNJ:Argentina

Address

One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.